# Efficacy and Safety of the <scp>TYK2</scp>/<scp>JAK1</scp> Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase <scp>IIb</scp> Randomized Controlled Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-the-scp-tyk2-scp-scp-jak1-scp-inhibitor-brepocitinib-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Philip J. Mease,Philip Helliwell,Paula Silwinska‐Stanczyk,Małgorzata Miakisz,Andrew J.K. Östör,Elena Peeva,Michael S. Vincent,Qiankun Sun,Vanja Sikirica,Randall Winnette,Ruolun Qiu,Gang Li,Gang Feng,Jean S. Beebe,David A. Martin |
| Citations | 65 |
| DOI | 10.1002/art.42519 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.42519 |
| OpenAlex ID | https://openalex.org/W4376872273 |
| PMID | 37194394 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Randall Winnette](https://scholariq.org/researchers/randall-winnette/)

## Paper journal

- [Arthritis & Rheumatology](https://scholariq.org/journals/arthritis-and-rheumatology/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.